Lavipharm S.A
Lavipharm S.A. engages in the research, development, manufacturing, import, marketing, sale, and wholesaling of pharmaceutical, dermocosmetic, and healthcare products in Greece and internationally. The company offers pharmaceutical products for cardiology, chronic pain and oncology, central nervous system, respiratory system, gastrointestinal system, and urology; and over the counter (OTC) drugs,… Read more
Lavipharm S.A (LAVI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2022: 0.013x
Based on the latest financial reports, Lavipharm S.A (LAVI) has a cash flow conversion efficiency ratio of 0.013x as of December 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€527.00K) by net assets (€40.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lavipharm S.A - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Lavipharm S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lavipharm S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lavipharm S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
402490
KQ:402490
|
-0.066x |
|
ELECO PLC LS-01
F:5H3
|
N/A |
|
Devyser Diagnostics AB
ST:DVYSR
|
0.000x |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
0.385x |
|
RideNow Group, Inc.
NASDAQ:RDNW
|
0.037x |
|
Tatry Mountain Resorts a.s.
PR:TMR
|
N/A |
|
Carindale Property Trust
AU:CDP
|
0.028x |
|
Quantafuel ASA
PINK:QNTFF
|
-0.069x |
Annual Cash Flow Conversion Efficiency for Lavipharm S.A (2014–2024)
The table below shows the annual cash flow conversion efficiency of Lavipharm S.A from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €52.97 Million | €4.64 Million | 0.088x | +1219.29% |
| 2023-12-31 | €42.77 Million | €284.00K | 0.007x | -92.01% |
| 2022-12-31 | €40.28 Million | €3.35 Million | 0.083x | +121.62% |
| 2021-12-31 | €-9.94 Million | €3.82 Million | -0.384x | -65.91% |
| 2020-12-31 | €-12.30 Million | €2.85 Million | -0.232x | -15.32% |
| 2019-12-31 | €-14.40 Million | €2.89 Million | -0.201x | -176.84% |
| 2018-12-31 | €-19.53 Million | €1.42 Million | -0.073x | +4.54% |
| 2017-12-31 | €-19.92 Million | €1.51 Million | -0.076x | -299.17% |
| 2016-12-31 | €-31.82 Million | €606.00K | -0.019x | -112.96% |
| 2015-12-31 | €-64.42 Million | €576.00K | -0.009x | +81.60% |
| 2014-12-31 | €-48.96 Million | €2.38 Million | -0.049x | -- |